This study aimed at providing health care decision makers with an up-to-date metric to measure the health benefit of health care products and programs.

In many studies, the 5-level EQ-5D questionnaire is considered a major improvement versus the 3-level version, to capture incremental changes in quality of life.

The availability of this value set will facilitate the publication of robust cost-effectiveness analyses, based on French surveys for different disease areas, whereas, up to now, the availability of such data has been recognized as one of the major limitations of the validity of such studies.